Literature DB >> 21214562

Phospholipases A2 and neural membrane dynamics: implications for Alzheimer's disease.

James C-M Lee1, Agnes Simonyi, Albert Y Sun, Grace Y Sun.   

Abstract

Phospholipases A(2) (PLA(2)s) are essential enzymes in cells. They are not only responsible for maintaining the structural organization of cell membranes, but also play a pivotal role in the regulation of cell functions. Activation of PLA(2) s results in the release of fatty acids and lysophospholipids, products that are lipid mediators and compounds capable of altering membrane microdomains and physical properties. Although not fully understood, recent studies have linked aberrant PLA(2) activity to oxidative signaling pathways involving NADPH oxidase that underlie the pathophysiology of a number of neurodegenerative diseases. In this paper, we review studies describing the involvement of cytosolic PLA(2) in oxidative signaling pathways leading to neuronal impairment and activation of glial cell inflammatory responses. In addition, this review also includes information on the role of cytosolic PLA(2) and exogenous secretory PLA(2) on membrane physical properties, dynamics, and membrane proteins. Unraveling the mechanisms that regulate specific types of PLA(2)s and their effects on membrane dynamics are important prerequisites towards understanding their roles in the pathophysiology of Alzheimer's disease, and in the development of novel therapeutics to retard progression of the disease.
© 2011 The Authors. Journal of Neurochemistry © 2011 International Society for Neurochemistry.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21214562      PMCID: PMC3058290          DOI: 10.1111/j.1471-4159.2010.07033.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  80 in total

1.  Arachidonic acid potently inhibits both postsynaptic-type Kv4.2 and presynaptic-type Kv1.4 IA potassium channels.

Authors:  Plamena R Angelova; Wolfgang S Müller
Journal:  Eur J Neurosci       Date:  2009-05-11       Impact factor: 3.386

2.  Pro-inflammatory secretory phospholipase A2 type IIA binds to integrins alphavbeta3 and alpha4beta1 and induces proliferation of monocytic cells in an integrin-dependent manner.

Authors:  Jun Saegusa; Nobuaki Akakura; Chun-Yi Wu; Case Hoogland; Zi Ma; Kit S Lam; Fu-Tong Liu; Yoko K Takada; Yoshikazu Takada
Journal:  J Biol Chem       Date:  2008-07-17       Impact factor: 5.157

3.  Role of PKC and MAPK in cytosolic PLA2 phosphorylation and arachadonic acid release in primary murine astrocytes.

Authors:  Jianfeng Xu; Yu-I Weng; Agnes Simonyi; Brent W Krugh; Zhongji Liao; Gary A Weisman; Grace Y Sun; Agnes Simoni
Journal:  J Neurochem       Date:  2002-10       Impact factor: 5.372

4.  Induction of secretory phospholipase A2 in reactive astrocytes in response to transient focal cerebral ischemia in the rat brain.

Authors:  Teng-Nan Lin; Qun Wang; Agnes Simonyi; Jean-Ju Chen; Wai-Mui Cheung; Yong Y He; Jan Xu; Albert Y Sun; Chung Y Hsu; Grace Y Sun
Journal:  J Neurochem       Date:  2004-08       Impact factor: 5.372

5.  Ser515 phosphorylation-independent regulation of cytosolic phospholipase A2alpha (cPLA2alpha) by calmodulin-dependent protein kinase: possible interaction with catalytic domain A of cPLA2alpha.

Authors:  Masaya Shimizu; Hiroyuki Nakamura; Tetsuya Hirabayashi; Akiko Suganami; Yutaka Tamura; Toshihiko Murayama
Journal:  Cell Signal       Date:  2008-01-04       Impact factor: 4.315

6.  Prostaglandin synthesis in rat brain astrocytes is under the control of the n-3 docosahexaenoic acid, released by group VIB calcium-independent phospholipase A2.

Authors:  Mikhail Strokin; Marina Sergeeva; Georg Reiser
Journal:  J Neurochem       Date:  2007-06-06       Impact factor: 5.372

7.  Secretory phospholipase A2 type III enhances alpha-secretase-dependent amyloid precursor protein processing through alterations in membrane fluidity.

Authors:  Xiaoguang Yang; Wenwen Sheng; Yan He; Jiankun Cui; Mark A Haidekker; Grace Y Sun; James C-M Lee
Journal:  J Lipid Res       Date:  2009-10-05       Impact factor: 5.922

8.  Secreted phospholipase A2 type IIA as a mediator connecting innate and adaptive immunity: new role in atherosclerosis.

Authors:  Elvira Ibeas; Lucía Fuentes; Rubén Martín; Marita Hernández; Maria Luisa Nieto
Journal:  Cardiovasc Res       Date:  2008-08-28       Impact factor: 10.787

Review 9.  Altered lipid metabolism in brain injury and disorders.

Authors:  Rao Muralikrishna Adibhatla; J F Hatcher
Journal:  Subcell Biochem       Date:  2008

Review 10.  Phospholipase A2 and its molecular mechanism after spinal cord injury.

Authors:  Nai-Kui Liu; Xiao-Ming Xu
Journal:  Mol Neurobiol       Date:  2010-02-03       Impact factor: 5.682

View more
  27 in total

1.  The glycerophosphocholine acyltransferase Gpc1 is part of a phosphatidylcholine (PC)-remodeling pathway that alters PC species in yeast.

Authors:  Sanket Anaokar; Ravindra Kodali; Benjamin Jonik; Mike F Renne; Jos F H M Brouwers; Ida Lager; Anton I P M de Kroon; Jana Patton-Vogt
Journal:  J Biol Chem       Date:  2018-12-04       Impact factor: 5.157

Review 2.  Regulation of complement factor H (CFH) by multiple miRNAs in Alzheimer's disease (AD) brain.

Authors:  Walter J Lukiw; Peter N Alexandrov
Journal:  Mol Neurobiol       Date:  2012-08       Impact factor: 5.590

Review 3.  Role of cytosolic calcium-dependent phospholipase A2 in Alzheimer's disease pathogenesis.

Authors:  M T Gentile; M G Reccia; P P Sorrentino; E Vitale; G Sorrentino; A A Puca; L Colucci-D'Amato
Journal:  Mol Neurobiol       Date:  2012-05-31       Impact factor: 5.590

Review 4.  Mechanisms of neuronal membrane sealing following mechanical trauma.

Authors:  Benjamin K Hendricks; Riyi Shi
Journal:  Neurosci Bull       Date:  2014-07-04       Impact factor: 5.203

5.  Severe disturbance in the Ca2+ signaling in astrocytes from mouse models of human infantile neuroaxonal dystrophy with mutated Pla2g6.

Authors:  Mikhail Strokin; Kevin L Seburn; Gregory A Cox; Kimberly A Martens; Georg Reiser
Journal:  Hum Mol Genet       Date:  2012-03-22       Impact factor: 6.150

Review 6.  Integrating cytosolic phospholipase A₂ with oxidative/nitrosative signaling pathways in neurons: a novel therapeutic strategy for AD.

Authors:  Grace Y Sun; Yan He; Dennis Y Chuang; James C Lee; Zezong Gu; Agnes Simonyi; Albert Y Sun
Journal:  Mol Neurobiol       Date:  2012-04-03       Impact factor: 5.590

7.  Alteration of mitochondrial phospholipid due to the PLA2 activation in rat brains under cadmium toxicity.

Authors:  Chinnarasu Sivaprakasam; Rajendran Vijayakumar; Mathivanan Arul; Vasanthi Nachiappan
Journal:  Toxicol Res (Camb)       Date:  2016-10-03       Impact factor: 3.524

8.  Evidence of altered phosphatidylcholine metabolism in Alzheimer's disease.

Authors:  Luke Whiley; Arundhuti Sen; James Heaton; Petroula Proitsi; Diego García-Gómez; Rufina Leung; Norman Smith; Madhav Thambisetty; Iwona Kloszewska; Patrizia Mecocci; Hilkka Soininen; Magda Tsolaki; Bruno Vellas; Simon Lovestone; Cristina Legido-Quigley
Journal:  Neurobiol Aging       Date:  2013-09-13       Impact factor: 4.673

9.  Effects of Acetylcholine on β-Amyloid-Induced cPLA2 Activation in the TB Neuroectodermal Cell Line: Implications for the Pathogenesis of Alzheimer's Disease.

Authors:  Arianna Polverino; Manuela Grimaldi; Pierpaolo Sorrentino; Francesca Jacini; Anna Maria D'Ursi; Giuseppe Sorrentino
Journal:  Cell Mol Neurobiol       Date:  2017-10-09       Impact factor: 5.046

Review 10.  Mini review-vanadium-induced neurotoxicity and possible targets.

Authors:  Madhuri Ramji Jaiswal; Pravin Popatrao Kale
Journal:  Neurol Sci       Date:  2019-12-14       Impact factor: 3.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.